Results 71 to 80 of about 990,521 (271)

PK-toimialabarometri : Sahateollisuus, kevät 2017

, 2017
Suomen pk-yritysten odotukset lähiajan suhdannenäkymistä ovat jatkuneet positiivisina syksystä 2016. Koko maan pk-yrityksistä 44 % arvioi suhdanteiden paranevan ja 9 % huononevan. Saldoluku on nyt +35 kun se edellisellä mittauskierroksella oli +32.
Loukasmäki, Pasi
core  

Pentoxifylline dose finding trial in preterm neonates with suspected late onset sepsis (PTX‐trial)

British Journal of Clinical Pharmacology, EarlyView.
Aim The aim of this study (PTX‐trial) is to determine the optimal dose of pentoxifylline (PTX) in preterm neonates (gestational age < 30 weeks) with (suspected) late onset sepsis (LONS). Methods The PTX‐trial is a prospective multicentre open‐label sequential dose‐optimization study with an adapted continual reassessment method.
Serife Kurul, H. Rob Taal, Jan Mazela, Ryszard Lauterbach, Irwin K. M. Reiss, Karel Allegaert, Robert B. Flint, Sinno H. P. Simons   +7 more
wiley   +1 more source

PK-toimialabarometri : Matkailu, kevät 2016

, 2016
Matkailualan pk-yritysten suhdannenäkymät henkilökunnan määrän suhteen ovat saldo-luvun perusteella positiivisemmat kuin syksyllä 2015. 20 % alan pk-yritysten edustajista arvioi henkilökunnan määrän olevan vuoden kuluttua tämän hetkistä suurempi ja 12 ...
Jänkälä, Susanna
core  

S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double‐blind randomized clinical trial in patients with mild to moderate atopic dermatitis

British Journal of Clinical Pharmacology, EarlyView.
Aim Recovering dysbiosis may improve atopic dermatitis (AD) symptoms. XZ.700 is a recombinant chimeric endolysin that specifically targets Staphylococcus aureus and could be a new treatment option for patients with AD. The aim of this first‐in‐human study was to evaluate the safety, tolerability and efficacy of topical XZ.700 and explore the ...
Laura W. J. van der Meulen, Menthe E. Bergmans, Salma Assil, Naomi Klarenbeek, Marieke L. de Kam, Alexa J. Tibboel, Thorsten Brach, Bjorn L. Herpers, Johan Frieling, Vincent de Jong, Benthe Freyee, Martijn B. A. van Doorn, Robert Rissmann, Tessa Niemeyer–van der Kolk   +13 more
wiley   +1 more source

From Stakeholder Pressure to Strategic Advantage: A Framework of Achieving Environment Sustainability Through Pathway of Carbon Neutrality

Business Strategy and the Environment, EarlyView.
ABSTRACT Businesses are increasingly striving to reduce their carbon footprint, with carbon offsetting emerging as a viable pathway towards achieving carbon neutrality. Such efforts signify a demonstrated commitment to fostering environmental sustainability and contributing to a more sustainable future.
Sanjeev Yadav, Ashutosh Samadhiya, Anil Kumar, Sunil Luthra, Krishan Kumar Pandey   +4 more
wiley   +1 more source

Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis

Clinical Pharmacology: Advances and Applications, 2016
Jonathan Q Tran,1 Ahmed A Othman,2,3 Alvydas Mikulskis,4 Paul Wolstencroft,5 Jacob Elkins6 1Clinical Pharmacology, Biogen, Cambridge, MA, USA; 2Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA; 3Faculty of Pharmacy, Cairo ...
Tran JQ, Othman AA, Mikulskis A, Wolstencroft P, Elkins J   +4 more
doaj  

PK-toimialabarometri : Puutuoteteollisuus, syksy 2016

, 2016
Suomen pk-yritysten yleiset suhdannenäkymät ovat kehittyneet myönteisesti keväästä 2016. Koko maan pk-yrityksistä 43 % arvioi suhdanteiden paranevan ja 11 % huononevan (saldoluku +32).

core  

Towards Strong Sustainability: Exploring Reconfigurations of Sufficiency‐Oriented and Regenerative Business Models

Business Strategy and the Environment, EarlyView.
ABSTRACT Despite increasing adoption of sustainable business models, environmental decline and social disparities continue to accelerate. Strong sustainable business models offer an alternative by prioritizing ecological limits and systemic change. Drawing on an integrative literature review and business model modularization, this study examines how ...
Maike Gossen, Katrin Pakizer, Maren Kropfeld, Nancy Bocken   +3 more
wiley   +1 more source

Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease

Drug Design, Development and Therapy, 2012
Kim Nordfjeld, Hans Andreasen, Lars L ThomsenPharmacosmos A/S, Holbaek, DenmarkBackground: Iron isomaltoside 1000 is a novel injectable iron compound which offers potential advantages in the treatment of subjects with iron-deficiency anemia.
Nordfjeld K, Andreasen H, Thomsen LL
doaj  

PK-toimialabarometri : Elintarviketeollisuus, syksy 2016

, 2016
Suomen pk-yritysten suhdannenäkymät ovat kehittyneet myönteisesti syksystä 2015. Koko maan pk-yrityksistä 43 % arvioi suhdanteiden paranevan ja 11 % huononevan (saldoluku +32, syksyllä 2015 +9).

core